Denning DW, Pleuvry A, Cole DC (2013) Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol 51:361–370. https://doi.org/10.3109/13693786.2012.738312

Article  PubMed  Google Scholar 

Maturu VN, Agarwal R (2015) Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis. Clin Exp Allergy J Br Soc Allergy Clin Immunol 45:1765–1778. https://doi.org/10.1111/cea.12595

Article  CAS  Google Scholar 

Stevens DA, Moss RB, Kurup VP et al (2003) Allergic bronchopulmonary aspergillosis in cystic fibrosis–state of the art: cystic fibrosis foundation consensus conference. Clin Infect Dis Off Publ Infect Dis Soc Am 37(Suppl 3):S225-264. https://doi.org/10.1086/376525

Article  Google Scholar 

Riscili BP, Wood KL (2009) Noninvasive pulmonary Aspergillus infections. Clin Chest Med 30(315–335):vii. https://doi.org/10.1016/j.ccm.2009.02.008

Article  PubMed  Google Scholar 

Agarwal R, Sehgal IS, Dhooria S et al (2020) Allergic bronchopulmonary aspergillosis. Indian J Med Res 151:529–549. https://doi.org/10.4103/ijmr.IJMR_1187_19

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curran AK, Hava DL (2021) Allergic diseases caused by aspergillus species in patients with cystic fibrosis. Antibiot Basel Switz 10:357. https://doi.org/10.3390/antibiotics10040357

Article  CAS  Google Scholar 

Keown K, Abbott S, Kuzeljevic B et al (2019) An investigation into biomarkers for the diagnosis of ABPA and aspergillus disease in cystic fibrosis. Pediatr Pulmonol 54:1787–1793. https://doi.org/10.1002/ppul.24465

Article  PubMed  Google Scholar 

Kumar R (2003) Mild, moderate, and severe forms of allergic bronchopulmonary aspergillosis: a clinical and serologic evaluation. Chest 124:890–892. https://doi.org/10.1378/chest.124.3.890

Article  PubMed  Google Scholar 

Muthu V, Sehgal IS, Prasad KT et al (2022) Epidemiology and outcomes of allergic bronchopulmonary aspergillosis in the elderly. Mycoses 65:71–78. https://doi.org/10.1111/myc.13388

Article  CAS  PubMed  Google Scholar 

Agarwal R, Bansal S, Chakrabarti A (2017) Are allergic fungal rhinosinusitis and allergic bronchopulmonary aspergillosis lifelong conditions? Med Mycol 55:87–95. https://doi.org/10.1093/mmy/myw071

Article  CAS  PubMed  Google Scholar 

Agarwal R, Chakrabarti A (2010) Clinical Manifestations and Natural History of Allergic Bronchopulmonary Aspergillosis. In: Comarú Pasqualotto A (ed) Aspergillosis: From Diagnosis to Prevention. Springer, Netherlands, Dordrecht, pp 707–724

Google Scholar 

Agarwal R, Gupta D, Aggarwal AN et al (2006) Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 130:442–448. https://doi.org/10.1378/chest.130.2.442

Article  PubMed  Google Scholar 

Agarwal R, Chakrabarti A, Shah A et al (2013) Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy J Br Soc Allergy Clin Immunol 43:850–873. https://doi.org/10.1111/cea.12141

Article  CAS  Google Scholar 

Patterson R, Greenberger PA, Halwig JM et al (1986) Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146:916–918. https://doi.org/10.1001/archinte.146.5.916

Article  CAS  PubMed  Google Scholar 

Yasir M, Goyal A, Sonthalia S (2022) Corticosteroid Adverse Effects. In: StatPearls. StatPearls Publishing, Treasure Island (FL)

Tucker RM, Haq Y, Denning DW, Stevens DA (1990) Adverse events associated with itraconazole in 189 patients on chronic therapy. J Antimicrob Chemother 26:561–566. https://doi.org/10.1093/jac/26.4.561

Article  CAS  PubMed  Google Scholar 

Benitez LL, Carver PL (2019) Adverse effects associated with long-term administration of azole antifungal agents. Drugs 79:833–853. https://doi.org/10.1007/s40265-019-01127-8

Article  CAS  PubMed  Google Scholar 

Tverdek FP, Kofteridis D, Kontoyiannis DP (2016) Antifungal agents and liver toxicity: a complex interaction. Expert Rev Anti Infect Ther 14:765–776. https://doi.org/10.1080/14787210.2016.1199272

Article  CAS  PubMed  Google Scholar 

Zhou Z-X, Yin X-D, Zhang Y et al (2022) Antifungal drugs and drug-induced liver injury: a real-world study leveraging the FDA adverse event reporting system database. Front Pharmacol 13:891336. https://doi.org/10.3389/fphar.2022.891336

Article  CAS  PubMed  PubMed Central  Google Scholar 

Becker KL, Gresnigt MS, Smeekens SP et al (2015) Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients. Clin Exp Allergy J Br Soc Allergy Clin Immunol 45:423–437. https://doi.org/10.1111/cea.12354

Article  CAS  Google Scholar 

Gresnigt MS, Netea MG, van de Veerdonk FL (2012) Pattern recognition receptors and their role in invasive aspergillosis. Ann N Y Acad Sci 1273:60–67. https://doi.org/10.1111/j.1749-6632.2012.06759.x

Article  CAS  PubMed  Google Scholar 

Rivera A, Hohl T, Pamer EG (2006) Immune responses to Aspergillus fumigatus infections. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 12:47–49. https://doi.org/10.1016/j.bbmt.2005.09.007

Article  CAS  Google Scholar 

Agarwal R, Aggarwal AN, Gupta D, Jindal SK (2009) Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis 13:936–944

CAS  Google Scholar 

Humbert M, Bousquet J, Bachert C et al (2019) IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy. J Allergy Clin Immunol Pract 7:1418–1429. https://doi.org/10.1016/j.jaip.2019.02.030

Article  PubMed  Google Scholar 

Schuyler M (1998) The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J Lab Clin Med 131:194–196. https://doi.org/10.1016/s0022-2143(98)90089-0

Article  CAS  PubMed  Google Scholar 

Lewington-Gower E, Chan L, Shah A (2021) Review of current and future therapeutics in ABPA. Ther Adv Chronic Dis 12:20406223211047004. https://doi.org/10.1177/20406223211047003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eraso IC, Sangiovanni S, Morales EI, Fernández-Trujillo L (2020) Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review. Ther Adv Respir Dis 14:1753466620961648. https://doi.org/10.1177/1753466620961648

Article  CAS  PubMed  PubMed Central  Google Scholar 

Epps QJ, Epps KL, Zobell JT, Young DC (2020) Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: II. Therapies for allergic bronchopulmonary aspergillosis. Pediatr Pulmonol 55:3541–3572. https://doi.org/10.1002/ppul.25080

Article  PubMed  Google Scholar 

Li J-X, Fan L-C, Li M-H et al (2017) Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature. Respir Med 122:33–42. https://doi.org/10.1016/j.rmed.2016.11.019

Article  PubMed  Google Scholar 

Tanou K, Zintzaras E, Kaditis AG (2014) Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence. Pediatr Pulmonol 49:503–507. https://doi.org/10.1002/ppul.22937

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central  Google Scholar